Context Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $18 |
Gross Profit | -2 | -2 | 16 | |
EBITDA | -18,698 | -3,085 | -3,820 | -6,930 |
EBIT | -18,701 | -3,088 | -3,823 | -6,933 |
Net Income | -17,459 | -2,254 | -3,667 | -6,769 |
Net Change In Cash | 0 | 0 | 0 | 18 |
Free Cash Flow | 7,709 | -3,355 | -4,360 | -7,227 |
Cash | 84,801 | 101,536 | 10,089 | 14,449 |
Basic Shares | 80,481 | 54,958 | 15,966 | 15,966 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -12 | -9 | ||
EBITDA | -25,060 | -14,826 | -10,525 | -2,572 |
EBIT | -25,072 | -14,835 | -7,437 | -2,572 |
Net Income | -23,964 | -14,290 | -7,433 | 6,644 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -21,047 | -14,086 | -9,049 | -1,034 |
Cash | 14,449 | 35,497 | 49,635 | 341 |
Basic Shares | 15,966 | 15,966 | 15,966 | 10,959 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.22 |
2024-06-30 | -$0.04 |
2024-03-31 | -$0.23 |
2023-12-31 | -$0.42 |
